[Effectiveness of Saccharomyces Boulardii Combined with Phototherapy in the Treatment of Hyperbilirubinemia in Neonates: a Prospective Randomized Controlled Trial]

Overview

Journal Zhongguo Dang Dai Er Ke Za Zhi

Specialty Pediatrics

Date 2020 Nov 11

PMID 33172546

Citations 4

Authors

Wei Tang

Hong-Yan Lu

Qin Sun

Wei-Min Xu

Affiliations

Soon will be listed here.

Abstract

Objective: To study the effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates.

Methods: The neonates with hyperbilirubinemia who were hospitalized from January to December 2018 were enrolled and randomly divided into an observation group (n=61) and a control group (n=63). The neonates in the observation group were treated with phototherapy combined with Saccharomyces boulardii, and those in the control group were treated with phototherapy combined with placebo. Treatment outcomes were compared between the two groups. Fecal samples were collected 72 hours after treatment and 16s rRNA high-throughput sequencing was used to compare the features of gut microbiota between the two groups.

Results: There was no significant difference in the total serum bilirubin level between the two groups before treatment (P>0.05). At 24, 48, and 72 hours after treatment, the observation group had a significantly lower level of total serum bilirubin than the control group (P<0.05). Compared with the control group, the observation group had a significantly lower proportion of neonates requiring phototherapy again [20% (12/61) vs 75% (47/63), P<0.05]. Compared with the control group, the observation group had a significantly higher abundance of Bacteroides (P<0.05) and a significantly lower abundance of Escherichia coli and Staphylococcus in the intestine at 72 hours after treatment (P<0.05).

Conclusions: In neonates with hyperbilirubinemia, phototherapy combined with Saccharomyces boulardii can effectively reduce bilirubin level and prevent the recurrence of jaundice. Saccharomyces boulardii can favour the treatment outcome by regulating the gut microbiota of neonates.

Citing Articles

Effect of on Liver Diseases: A Systematic Review.

Maslennikov R, Benuni N, Levshina A, Adzhieva F, Demina T, Kucher A Microorganisms. 2024; 12(8).

PMID: 39203520 PMC: 11357183. DOI: 10.3390/microorganisms12081678.

What Happens in the Gut during the Formation of Neonatal Jaundice-Underhand Manipulation of Gut Microbiota?.

Su H, Yang S, Chen S, Chen X, Guo M, Zhu L Int J Mol Sci. 2024; 25(16).

PMID: 39201270 PMC: 11354725. DOI: 10.3390/ijms25168582.

Preventive effect of prenatal maternal oral probiotic supplementation on neonatal jaundice (POPS Study): A protocol for the randomised double-blind placebo-controlled clinical trial.

Alemu B, Lee M, Leung M, Lee W, Wang Y, Wang C BMJ Open. 2024; 14(6):e083641.

PMID: 38851232 PMC: 11163667. DOI: 10.1136/bmjopen-2023-083641.

Impact of Saccharomyces boulardii on jaundice in premature infants undergoing phototherapy.

Hu D, Wang Y, Yang S, Zhang H J Pediatr (Rio J). 2022; 99(3):263-268.

PMID: 36574954 PMC: 10202724. DOI: 10.1016/j.jped.2022.10.010.

References

Demirel G, Celik I, Erdeve O, Dilmen U . Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants. J Matern Fetal Neonatal Med. 2012; 26(2):215-8. DOI: 10.3109/14767058.2012.725115. View

Pollet R, DAgostino E, Walton W, Xu Y, Little M, Biernat K . An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. Structure. 2017; 25(7):967-977.e5. PMC: 5533298. DOI: 10.1016/j.str.2017.05.003. View

Kopelman A, Brown R, ODELL G . The "bronze" baby syndrome: a complication of phototherapy. J Pediatr. 1972; 81(3):466-72. DOI: 10.1016/s0022-3476(72)80172-0. View

Jimenez E, Marin M, Martin R, Odriozola J, Olivares M, Xaus J . Is meconium from healthy newborns actually sterile?. Res Microbiol. 2008; 159(3):187-93. DOI: 10.1016/j.resmic.2007.12.007. View

Foster T, Geoghegan J, Ganesh V, Hook M . Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2013; 12(1):49-62. PMC: 5708296. DOI: 10.1038/nrmicro3161. View

Serce O, Gursoy T, Ovali F, Karatekin G . Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial. Am J Perinatol. 2014; 30(2):137-42. DOI: 10.1055/s-0034-1376390. View

Bhutani V, Vilms R, Hamerman-Johnson L . Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol. 2010; 30 Suppl:S6-15. DOI: 10.1038/jp.2010.98. View

Dave M, Higgins P, Middha S, Rioux K . The human gut microbiome: current knowledge, challenges, and future directions. Transl Res. 2012; 160(4):246-57. DOI: 10.1016/j.trsl.2012.05.003. View

Leser T, Amenuvor J, Jensen T, Lindecrona R, Boye M, Moller K . Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl Environ Microbiol. 2002; 68(2):673-90. PMC: 126712. DOI: 10.1128/AEM.68.2.673-690.2002. View

10.

Creech C, Frenck Jr R, Sheldon E, Seiden D, Kankam M, Zito E . Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial. Vaccine. 2016; 35(2):385-394. DOI: 10.1016/j.vaccine.2016.11.032. View

11.

Wexler A, Goodman A . An insider's perspective: Bacteroides as a window into the microbiome. Nat Microbiol. 2017; 2:17026. PMC: 5679392. DOI: 10.1038/nmicrobiol.2017.26. View

12.

Winstel V, Missiakas D, Schneewind O . targets the purine salvage pathway to kill phagocytes. Proc Natl Acad Sci U S A. 2018; 115(26):6846-6851. PMC: 6042115. DOI: 10.1073/pnas.1805622115. View

13.

Wallace B, Roberts A, Pollet R, Ingle J, Biernat K, Pellock S . Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. Chem Biol. 2015; 22(9):1238-49. PMC: 4575908. DOI: 10.1016/j.chembiol.2015.08.005. View

14.

Najati N, Gharebaghi M, Mortazavi F . Underlying etiologies of prolonged icterus in neonates. Pak J Biol Sci. 2011; 13(14):711-4. DOI: 10.3923/pjbs.2010.711.714. View

15.

Palmer C, Bik E, DiGiulio D, Relman D, Brown P . Development of the human infant intestinal microbiota. PLoS Biol. 2007; 5(7):e177. PMC: 1896187. DOI: 10.1371/journal.pbio.0050177. View

16.

Rocha E, Jeffrey Smith C . Ferritin-like family proteins in the anaerobe Bacteroides fragilis: when an oxygen storm is coming, take your iron to the shelter. Biometals. 2013; 26(4):577-91. PMC: 3815548. DOI: 10.1007/s10534-013-9650-2. View

17.

Maayan-Metzger A, Yosipovitch G, Hadad E, Sirota L . Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol. 2001; 18(7):393-6. DOI: 10.1055/s-2001-18698. View

18.

Liu W, Liu H, Wang T, Tang X . Therapeutic effects of probiotics on neonatal jaundice. Pak J Med Sci. 2015; 31(5):1172-5. PMC: 4641277. DOI: 10.12669/pjms.315.7921. View

19.

Aspberg S, Dahlquist G, Kahan T, Kallen B . Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?. Pediatr Allergy Immunol. 2007; 18(4):313-9. DOI: 10.1111/j.1399-3038.2006.00518.x. View

20.

Henny-Harry C, Trotman H . Epidemiology of neonatal jaundice at the University Hospital of the West Indies. West Indian Med J. 2012; 61(1):37-42. View